Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
8,904
Total Claims
$1.0M
Drug Cost
627
Beneficiaries
$1,618
Cost/Patient
Risk Score Breakdown 9/100
Score components are additive. Read full methodology
Peer Comparison vs. 218,535 Nurse Practitioner providers
-25%
Opioid rate vs peers
2.8% vs 3.8% avg
+38%
Cost per patient vs peers
$1,618 vs $1,174 avg
+79%
Brand preference vs peers
15.9% vs 8.9% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
2.8%
Opioid Rate
253
Opioid Claims
$4,413
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,407 claims · $842K
Generic: 7,444 claims · $168K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Semaglutide | 88 | $131K |
| Apixaban | 102 | $93K |
| Empagliflozin | 51 | $69K |
| Dulaglutide | 41 | $62K |
| Sitagliptin Phosphate | 30 | $38K |
| Tirzepatide | 31 | $37K |
| Insulin Glargine,hum.Rec.Anlog | 48 | $32K |
| Insulin Detemir | 31 | $31K |
| Fluticasone/Umeclidin/Vilanter | 28 | $24K |
| Evolocumab | 27 | $23K |
| Rivaroxaban | 19 | $23K |
| Budesonide/Formoterol Fumarate | 46 | $20K |
| Insulin Lispro | 20 | $16K |
| Fluticasone Propion/Salmeterol | 18 | $12K |
| Umeclidinium Bromide | 28 | $12K |
Prescribing Profile
Patient Profile
70
Avg Age
64%
Female
1.38
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About